Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia

Afr Health Sci. 2016 Sep;16(3):677-683. doi: 10.4314/ahs.v16i3.6.

Abstract

Background: Occult hepatitis B infections are becoming a major global threat, but the available data on its prevalence in various parts of the world are often divergent.

Objective: This study aimed to detect occult hepatitis B virus in hepatitis B surface antigen-negative serum using anti-HBc as a marker of previous infection.

Patient and methods: A total of 1000 randomly selected hepatitis B surface antigen-negative sera from blood donors were tested for hepatitis B core antibody and hepatitis B surface antibody using an ELISA and nested polymerase chain reaction was done using primers specific to the surface gene (S-gene).

Results: Of the 1000 samples 55 (5.5%) were found to be reactive, of which 87.3% (48/55) were positive for hepatitis B surface antibody, indicating immunity as a result of previous infection however, that does not exclude active infection with escaped mutant HBV. Nested PCR results showed the presence of hepatitis B viral DNA in all the 55 samples that were positive for core protein, which is in agreement with the hepatitis B surface antibody result.

Conclusion: This study reveals the 5.5% prevalence of occult hepatitis B among Malaysian blood donors as well as the reliability of using hepatitis B core antibody in screening for occult hepatitis B infection in low endemic, low socioeconomic settings.

Keywords: Hepatitis B; core antibody; occult hepatitis B infection; polymerase chain reaction; surface antigen.

MeSH terms

  • Blood Donors*
  • Enzyme-Linked Immunosorbent Assay
  • Hepatitis B / diagnosis*
  • Hepatitis B / epidemiology
  • Hepatitis B Antibodies / blood
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Malaysia / epidemiology
  • Polymerase Chain Reaction
  • Prevalence

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens